New biomarker for early prediction of response to CAR-T cell therapy
A research team has discovered a highly potent biomarker for clinical response to CAR-T cell therapy, describing the prerequisites for optimal use of this novel therapy for lymphoma treatment. The current findings are an essential step forward towards optimizing this promising therapy.
Materials provided by Medical University of Vienna. Note: Content may be edited for style and length.
Source link aaaaa